NCT01915407View on ClinicalTrials.gov

AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Platelet Dysfunction Due to Aspirin Ingestion
Trial Locations (1)

77099

Aggredyne, Inc., Houston

Sponsors

Lead Sponsor

Aggredyne, Inc.
All Listed Sponsors
lead

Aggredyne, Inc.

INDUSTRY

NCT01915407 - AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction | Biotech Hunter | Biotech Hunter